E
Ultragenyx Pharmaceutical Inc. RARE
$29.78 $0.260.88% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 610.16M 590.69M 560.23M 522.75M 481.30M
Total Other Revenue -- -- -- -- --
Total Revenue 610.16M 590.69M 560.23M 522.75M 481.30M
Cost of Revenue 1.12B 1.11B 1.11B 1.06B 1.05B
Gross Profit -507.79M -522.31M -554.35M -537.58M -568.99M
SG&A Expenses 337.29M 331.25M 321.61M 315.95M 310.51M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 1.12B 1.10B 1.10B 1.06B 1.03B
Operating Income -505.09M -513.57M -535.97M -535.74M -548.85M
Income Before Tax -530.39M -547.13M -567.59M -561.07M -586.86M
Income Tax Expenses 2.54M 2.45M 1.60M -2.09M -1.74M
Earnings from Continuing Operations -532.93 -549.58 -569.18 -558.99 -585.12
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -532.93M -549.58M -569.18M -558.99M -585.12M
EBIT -505.09M -513.57M -535.97M -535.74M -548.85M
EBITDA -469.65M -477.88M -500.43M -501.06M -515.74M
EPS Basic -5.53 -5.88 -6.34 -6.46 -7.29
Normalized Basic EPS -3.43 -3.62 -3.94 -4.07 -4.57
EPS Diluted -5.53 -5.88 -6.34 -6.46 -7.29
Normalized Diluted EPS -3.43 -3.62 -3.94 -4.07 -4.57
Average Basic Shares Outstanding 385.92M 374.04M 362.04M 347.48M 323.65M
Average Diluted Shares Outstanding 385.92M 374.04M 362.04M 347.48M 323.65M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --